Phyllis Q. Karavatakis
CIK 1824976 · View on SEC EDGAR ↗
Insider
First SEC filing: May 4, 2021 · Latest: May 4, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 3, 2021 | CARE | P 10b5-1 | 37 | $13.20 | $488 | 17,894 Direct | +0.21% | Acquired | 137.3% (price as of 2026-08-21) |
| April 1, 2021 | CARE | P 10b5-1 | 36 | $13.95 | $502 | 17,857 Direct | +0.20% | Acquired | 124.5% (price as of 2026-08-21) |
| March 1, 2021 | CARE | P 10b5-1 | 40 | $12.27 | $491 | 17,821 Direct | +0.22% | Acquired | 155.3% (price as of 2026-08-21) |
| Feb. 1, 2021 | CARE | P 10b5-1 | 49 | $10.05 | $492 | 17,781 Direct | +0.28% | Acquired | 211.6% (price as of 2026-08-21) |
| Jan. 4, 2021 | CARE | P 10b5-1 | 46 | $10.63 | $489 | 17,732 Direct | +0.26% | Acquired | 194.6% (price as of 2026-08-21) |
| Dec. 1, 2020 | CARE | P 10b5-1 | 50 | $9.90 | $495 | 17,686 Direct | +0.28% | Acquired | 216.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $247,869 | — | — | — | $25,000 | — | $36,441 | $309,310 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.